GlassScriptPhysician profile
Christopher J Ogrady
NPI 1861474306
$2,206.21
in general payments reported to CMS, 2019-2025
18 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $158 · 2021: $88.62 · 2022: $90.78 · 2023: $1,543 · 2024: $184 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,253 · Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,252.84 |
| Food and Beverage | $615.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $1,443.36 | 2023 | |
| Smith+Nephew, INC. | $108.48 | 2020 | |
| Dexcom, INC. | $100.89 | 2022-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $87.90 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $86.23 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $73.89 | 2022-2024 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $43.76 | 2023 | Rexulti |
| Glaxosmithkline, LLC. | $36.57 | 2024-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.94 | 2021 | |
| Radius Health, INC. | $33.28 | 2020 | |
| Viiv Healthcare Company | $28.17 | 2024 | Apretude |
| Phathom Pharmaceuticals, INC. | $23.28 | 2024 | Voquezna |
| Abbvie INC. | $18.44 | 2022 | |
| Boston Scientific Corporation | $18.16 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.76 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $16.86 | 2023 | |
| Eisai INC. | $16.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ogrady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.